The systemic treatment options for advanced gastric cancer (GC) have evolved rapidly in recent years. We have reviewed the recent data of clinical trial incorporating targeted agents, including inhibitors of angiogenesis, human epidermal growth factor receptor 2 (HER2), mesenchymal-epithelial transi...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!